Medical therapy for acute ischemic stroke.

被引:3
作者
Goldstein L.B. [1 ]
机构
[1] Duke Center for Cerebrovascular Disease, Stroke Policy Program, Center for Clinical Health Policy Research, Duke University Medical Center, Box 3651, Durham, 27710, NC
关键词
Acute Stroke; Acute Ischemic Stroke; Thrombolytic Therapy; Stroke Care; Retinal Artery Occlusion;
D O I
10.1007/s11883-001-0023-x
中图分类号
学科分类号
摘要
Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.
引用
收藏
页码:299 / 306
页数:7
相关论文
共 185 条
[1]  
Goldstein LB(1998)North Carolina Stroke Prevention and Treatment Facilities Survey: statewide availability of rt-PA for acute ischemic stroke Stroke 29 2069-2072
[2]  
Hey LA(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587
[3]  
Laney R(1997)Clinical debate. Should thrombolytic therapy be first-line treatment for acute stroke? N Engl J Med 337 1309-1313
[4]  
Marler JR(1996)Thrombolysis for stroke Arch Neurol 53 1305-1306
[5]  
Brott T(1996)Tissue-type plasminogen activator should not be used in acute ischemic stroke Arch Neurol 53 1306-1308
[6]  
Broderick J(1997)Thrombolytic therapy in acute ischemic stroke: the jury needs more evidence Med J Aust 166 419-422
[7]  
Caplan LR(1997)Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke Lancet 350 607-614
[8]  
Mohr JP(1999)Effects of tissue plasminogen activator for acute ischemic stroke at one year N Engl J Med 340 1781-1787
[9]  
Kistler JP(1998)Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke Neurology 50 883-890
[10]  
Brott T(1992)Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes Stroke 23 632-640